VA Launches Psilocybin Trial for Veterans with Treatment-Resistant Depression
- Published:
- First detected:
Insights by Echo AI
The U.S. Department of Veterans Affairs has initiated a clinical trial to assess the safety and effectiveness of psilocybin in treating major depression, including cases concurrent with PTSD, that has not responded to other treatments. The randomized trial will compare two psilocybin dosage levels and evaluate depression levels, side effects, and patient-reported outcomes. This trial is part of VA's 20 active clinical trials exploring psychedelic therapies for mental health conditions, conducted under strict safety protocols and federal guidelines.
Source coverage
4
records merged
3
3 unique
0
0 unique
1
1 unique
4 Sources
VA Launches Psilocybin Trial For Veterans With Treatment-Resistant Dep...
VA Launches Psilocybin Trial For Veterans With Treatment-Resistant Dep...
This is awesome. The U.S. Department of Veterans Affairs has launched...
Unlock Echo Intelligence
Move beyond the public feed. Monitor breaking stories across Telegram, X, and the web — with earlier visibility, clearer context, and complete control over your sources.
- Monitor Telegram, X, and web in one place
- Add any source, from niche channels to global outlets
- Build custom feeds around events, regions, entities, or keywords
- Merge duplicate coverage into one clear, source-transparent story
- Auto-translate summaries and full articles
- Search past coverage and use AI-powered editorial tools
